Messoud Ashina, Danish Headache Center and Department of Neurology, Glostrup Hospital, University of Copenhagen, Denmark
David Bleakman, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, USA
Peter R. Blower, Minster Pharmaceuticals plc, Saffron Walden, Essex, UK
Kevin C. Brennan, Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, USA
Hans Bräuner-Osborne, Department of Medical Chemistry, Faculty of Pharmaceutical Sciences, University of Copenhagen, Denmark
Simona Buscone, University Centre for the Study of Adaptive Disorder and Headache (UCADH), University of Pavia, Italy
Andrew C. Charles, Headache Research and Treatment Program, Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, USA
Bolette Christiansen, Department of Medical Chemistry, Faculty of Pharmaceutical Sciences, University of Copenhagen, Denmark
Boris A. Chizh, GlaxoSmithKline, Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, Cambridge, UK
Amy Clemens-Smith, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, USA
S. Colnaghi, Laboratory of Ocular Movements, Foundation IRCCS "C. Mondino", Pavia, Italy
Carl G.H. Dahlöf, Institute of Neuroscience and Physiology, Department of Clinical Neuroscience and Rehabilitation, Sahlgrenska University Hospital, Sweden
Veronique Dehlinger, Eli Lilly and Co Ltd, Lilly Research Centre, Surrey, UK
Colin P. Dell, Eli Lilly and Co Ltd, Lilly Research Centre, Surrey, UK
Donna K. Dieckman, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, USA
Lars Edvinsson, Clinical Experimental Research, Glostrup Research Institute, Glostrup Hospital, Denmark
Michel D. Ferrari, Leiden University Medical Centre, The Netherlands
Sandra A.Filla, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, USA
Beatriz Fioravanti, Department of Pharmacology, University of Arizona, USA
Rosaria Greco, IRCCS Neurological Institute "C Mondino Foundation", Pavia, Italy
Jacob Møller Hansen, Danish Headache Center and Department of Neurology, Glostrup Hospital, University of Copenhagen, Glostrup, Denmark
Kevin J. Hudziak, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, USA
Inger Jansen-Olesen, Department of Neurology and Danish Headache Centre, Glostrup Research Institute, University of Copenhagen, Denmark
Anders A. Jensen, Department of Medical Chemistry, Faculty of Pharmaceutical Sciences, University of Copenhagen, Denmark
Rigmor Jensen, Danish Headache Center and Department of Neurology, Glostrup Hospital, University of Copenhagen, Denmark
Kirk W. Johnson, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, USA
Michael P. Johnson, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, USA
Louise Juhl, Department of Neurology, Glostrup Research Institute, Glostrup Hospital, Glostrup, Denmark
Trine Kvist, Department of Medical Chemistry, Faculty of Pharmaceutical Sciences, University of Copenhagen, Denmark
E. Marchioni, Department of Clinical Neurology, IRCCS Neurological Institute "C Mondino Foundation", Pavia, Italy
Giuseppe Nappi, Scientific Direction, IRCCS Foundation "C. Mondino" , Pavia, Italy, and Department of Neurology and ORL, University "La Sapienza", Rome, Italy and Headache Unit and University Centre for Adaptive Disorders and Headache (UCADH), Pavia, Italy
Eric S. Nisenbaum, Eli Lilly and Co Ltd, Lilly Research Centre, Surrey, UK
Jes Olesen, Department of Neurology and Danish Headache Centre, Glostrup Hospital, University of Copenhagen, Denmark
Paul L. Ornstein, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, USA
Armando Perrotta, University Centre for the Study of Adaptive Disorder and Headache (UCADH), University of Pavia, Italy
A. Pichiecchio, Neuroradiology Department, Foundation IRCCS "C. Mondino", Pavia, Italy
Kenneth Beri Ploug, Departments of Neurology and Danish Headache Centre, Glostrup Research Institute, Glostrup Hospital, University of Copenhagen, Denmark
Alexandra Maria Rahmann, Department of Neurology, University Hospital Münster, Germany
Nabih M. Ramadan, Rosalind Franklin University of Medicine & Science, Chigago, USA
Michael A. Rogawski, Department of Neurology, School of Medicine, University of California, Sacramento, USA
Giorgio Sandrini, University Centre for the Study of Adaptive Disorder and Headache (UCADH), University of Pavia, Italy and IRCCS Neurological Institute "C.Mondino Foundation", Pavia, Italy
Pramod R. Saxena, Department of Pharmacology, ErasmusMC, University Medical Center, Rotterdam, The Netherlands
Paul C. Sharpe, Minster Pharmaceuticals plc, Saffron Walden, Essex, UK
Edward R. Siuda, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, USA
Cristina Tassorelli, University Centre for the Study of Adaptive Disorder and Headache (UCADH), University of Pavia, Italy and IRCCS Neurological Institute "C. Mondino Foundation", Pavia, Italy
E. Tavazzi, Department of Clinical Neurology, IRCCS Foundation "C. Mondino", Pavia, Italy
Peer Tfelt-Hansen, Department of Neurology, Glostrup Hospital, University of Glostrup, Denmark
Arn M.J.M. Van den Maagdenberg, Department of Neurology, Leiden University Medical Center Leiden, The Netherlands, and Department of Human Genetics, Leiden University Medical Center, The Netherlands
Todd W. Vanderah, Department of Pharmacology, University of Arizona, USA
M. Versino, Laboratory of Ocular Movements, Foundation IRCCS "C. Mondino", Pavia, Italy
Christian Waeber, Department of Radiology, Massachusetts General Hospital, USA
Troels Wienecke, Danish Headache Center and Department of Neurology, Glostrup Hospital, Faculty of Health Sciences, University of Copenhagen, Denmark
